Baxter International Inc. (BAX) - Product Pipeline Analysis, 2014 Update - New Market Study Published

Boston, MA -- (SBWIRE) -- 08/01/2014 -- Baxter International Inc. (Baxter) is a diversified global healthcare company. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It manufactures intravenous (IV) solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; IV nutrition products; infusion pumps; and inhalation anesthetics. It also offers recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The company operates in two divisions: BioScience and Medical Products. It has operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, the US.